vTv Therapeutics Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · High Point, NC
VTVT chart
What traders are saying about $VTVT
Latest postsvTv Therapeutics Inc. news
- vTv Therapeutics begins trial of cadisegliatin in T1D patients
Investing.com ·
- vTv Therapeutics Announces First Participant Randomized in Phase 2a Pilot Study Evaluating Cadisegliatin in Individuals with Type 1 Diabetes (T1D) Using Hybrid Closed-Loop (HCL) Insulin Delivery Systems
Yahoo Finance ·
- vTv Therapeutics Announces First Participant Randomized in
GlobeNewswire ·
- An estimated 2.1 million Americans live with type 1 diabetes. A trial tests an added pill with automated insulin systems.
Stock Titan ·
- vTv Therapeutics (NASDAQ:VTVT) Stock Bumped Down to Sell by Wall Street Zen
MarketBeat ·
- vTv Therapeutics Inc. Estimates – NASDAQ:VTVT
TradingView ·
- vTv Therapeutics Inc. (VTVT) Discusses Hypoglycemia Burden in Type 1 Diabetes and Cadisegliatin Phase 3 Program - Slideshow (NASDAQ:VTVT) 2026-10-21
Seeking Alpha ·
- vTv Therapeutics Highlights Cadisegliatin’s Phase III Push to Tackle Type 1 Hypoglycemia
marketbeat.com ·
- iOnctura appoints Paul Sekhri as Chair of its Board of Directors
Yahoo Finance ·
- vTv Therapeutics Announces Oral Presentation at Breakthrough T1D Clinical and Research Congress 2026
Yahoo Finance ·
- vTv Therapeutics stock jumps on FDA orphan drug status
Yahoo Finance ·
- vTv Therapeutics Announces FDA Orphan Drug Designation for HPPD in Sickle Cell Disease
Yahoo Finance ·
vTv Therapeutics Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $0 | $1.0M | $0 | $2.0M |
| Net income | -$27.0M | -$18.5M | -$20.3M | -$19.2M |
| Total assets (year end) | $89.9M | $38.3M | $11.0M | $33.2M |
| Cash and equivalents (year end) | $88.9M | $36.7M | $9.4M | $12.1M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About vTv Therapeutics Inc.
- Ticker
- VTVT (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- High Point, NC
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1641489
Frequently asked questions
What exchange is vTv Therapeutics Inc. listed on?
vTv Therapeutics Inc. trades on the Nasdaq under the ticker symbol VTVT.
What industry is vTv Therapeutics Inc. in?
vTv Therapeutics Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is vTv Therapeutics Inc. headquartered?
vTv Therapeutics Inc.'s business address on file with the SEC is in High Point, NC.
When does vTv Therapeutics Inc.'s fiscal year end?
vTv Therapeutics Inc.'s fiscal year ends on December 31.
How much revenue did vTv Therapeutics Inc. report?
vTv Therapeutics Inc. reported $0 in revenue for calendar year 2025, according to its SEC filings.